AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Exnib OD 11mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Zydus Cadila

Salt Composition

Tofacitinib (11mg)

Overview Exnib OD 11mg Tablet ER

Rheumacept XR 11mg extended-release tablets are indicated for moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. This medication alleviates joint pain, tenderness, and swelling by suppressing inflammation, and helps to retard the progression of bone and joint deterioration. Rheumacept XR 11mg may be administered alone or in conjunction with other medications. These tablets can be ingested with or without food, ideally at the same time daily. Dosage is individualized based on your specific condition and other medications. Always adhere to your physician's prescribed regimen. Discontinuing treatment without medical supervision could exacerbate your condition. Frequently reported side effects include upper respiratory infections, headache, diarrhea, and nasal inflammation. Less common, but potentially serious, adverse effects encompass blood clots and gastrointestinal perforations, requiring immediate medical attention. Consult your doctor concerning any concerns regarding side effects. Pre-treatment blood tests may be necessary, and initiation of therapy is contraindicated in the presence of any infection. Prior to commencing treatment, inform your physician of any history of tuberculosis, herpes zoster, hepatic or renal impairment, hepatitis B or C, or pulmonary or venous thromboembolism. Rheumacept XR 11mg can increase susceptibility to infection or worsen existing infections; therefore, minimize contact with individuals exhibiting contagious illnesses (e.g., varicella, rubeola, influenza). This medication is unsuitable for individuals under 18 years of age and should be avoided during pregnancy or breastfeeding unless deemed clinically beneficial by your physician. Regular monitoring by your doctor may be required.

Primary Ingredients of Exnib OD 11mg Tablet ER

No information provided. Please provide the text you wish me to rephrase.

Uses of Exnib OD 11mg Tablet ER

Management of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.

Major Benefits of Exnib OD 11mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Exnib OD 11mg Extended-Release Tablets can be administered with or without food, however, consistent timing is recommended.

Common Side effects of Exnib OD 11mg Tablet ER:

  • Upper respiratory tract infection
  • Headache
  • Diarrhea
  • Nasopharyngitis (inflammation of the throat and nasal passages)

How to use Exnib OD 11mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Exnib OD 11mg Extended-Release Tablet can be consumed with or without food, although consistent timing is recommended.

How Exnib OD 11mg Tablet ER works:

The extended-release Exnib 11mg tablet, taken once daily, is a Janus kinase (JAK) inhibitor. Its mechanism involves suppressing Janus kinase enzyme activity, thereby reducing immune system activation and inflammation characteristic of rheumatic conditions and ulcerative colitis.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse interactions between Exnib OD 11mg Tablet ER and alcohol consumption.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release 11mg Exnib OD tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Exnib 11mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk with possible infant harm.

DrivingDrivingSAFE

Driving ability is typically unaffected by the administration of one 11mg extended-release Exnib tablet daily.

KidneyKidneyCAUTION

Patients with severe kidney impairment should exercise caution when using Exnib OD 11mg Extended-Release tablets. Dosage modification may be necessary; physician consultation is advised.

LiverLiverCAUTION

Patients with severe hepatic impairment should exercise caution when using Exnib OD 11mg Extended-Release tablets. Dosage modification of Exnib OD 11mg Extended-Release tablets may be necessary. Physician consultation is advised.

What if you forget to take Exnib OD 11mg Tablet ER :

Should you forget a dose of your Exnib OD 11mg Extended-Release Tablet, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Exnib OD 11mg Tablet ER

LabelValue
Chemical Category Pyrrolopyrimidine compound
Developing Habits No.
Type of Therapy Pain Relievers
Action Class JAK inhibitors

FAQs on Exnib OD 11mg Tablet ER

Tell your doctor about any liver problems before starting Exnib OD 11mg Tablet ER. This medication may raise liver enzyme levels in some people, so your liver function should be checked beforehand. While Exnib OD 11mg Tablet ER can be used in patients with mild to moderate liver impairment, it's contraindicated in those with severe impairment.
Taking Exnib OD 11mg Tablet ER may raise your risk of certain cancers, such as lymphoma and skin cancer, due to its effects on the immune system. Tell your doctor if you have or have had any cancer.
Exnib OD 11mg Extended-Release tablets treat moderate to severe rheumatoid arthritis, a joint inflammatory disease. This medication is prescribed when prior treatments proved ineffective or unsuitable. It may also be used earlier if initial drug therapies fail, and can be administered alone or in conjunction with other medications like methotrexate.
You may start feeling better within 2 to 8 weeks of taking Exnib OD 11mg Extended-Release tablets, but it may take 3 to 6 months to experience the full benefits.
Before and during treatment with Exnib OD 11mg Tablet ER, blood tests may be necessary to monitor for anemia, neutropenia or lymphopenia, high cholesterol, and elevated liver enzymes. These tests help ensure the medication isn't causing adverse effects. Your doctor may also recommend a tuberculosis test beforehand, as Exnib OD 11mg Tablet ER could exacerbate an existing infection.
Exnib OD 11mg Tablet ER is an immunosuppressant, potentially lowering your resistance to infections, including serious ones like tuberculosis. It may increase the risk of severe, systemic fungal, bacterial, or viral infections, which can be life-threatening and require hospitalization.
Taking tocilizumab with Exnib OD 11mg Tablet ER is not recommended. Exnib OD 11mg Tablet ER's effect on the immune system means it shouldn't be combined with other immune-suppressing medications. Concurrent use increases infection risk and potential complications.
Exnib OD 11mg Tablet ER
972
MRP 1,125
13% off